Investment Thesis
Molina Healthcare faces severe profitability deterioration with net income declining 60% YoY despite 11.7% revenue growth, resulting in near-zero net margins (0.1%) and microscopic ROE/ROA (0.3%/0.1%). While strong operating cash flow ($1.1B) and solid balance sheet provide financial stability, the dramatic margin compression suggests fundamental operational or competitive challenges eroding shareholder value.
Strengths
- Strong revenue growth of 11.7% YoY demonstrates continued market demand for healthcare services
- Excellent cash generation with $1.1B operating cash flow and 9.8% FCF margin, providing financial flexibility
- Solid balance sheet with manageable leverage (0.92x D/E), adequate liquidity (1.63x current ratio), and $5.3B cash position
Risks
- Severe profitability collapse with net income down 60% YoY and net margin of 0.1%, indicating structural margin compression
- Microscopic returns on equity (0.3%) and assets (0.1%) signal capital is generating inadequate returns for shareholders
- Large disconnect between strong FCF and minimal net income suggests underlying operational issues, reserve builds, or adverse non-operating items requiring investigation
Key Metrics to Watch
- Net margin trajectory and operating expense growth rates - determine if 60% decline is temporary or permanent structural shift
- Medical loss ratios and premium trends - critical profitability drivers for healthcare insurers
- Operating cash flow sustainability and working capital movements - ensure cash generation persists independent of accounting reserves
Financial Metrics
Revenue
10.8B
Net Income
14.0M
EPS (Diluted)
$0.27
Free Cash Flow
1.1B
Total Assets
16.4B
Cash
5.3B
Profitability Ratios
Gross Margin
23.0%
Operating Margin
0.8%
Net Margin
0.1%
ROE
0.3%
ROA
0.1%
FCF Margin
9.8%
Balance Sheet & Liquidity
Current Ratio
1.63x
Quick Ratio
1.63x
Debt/Equity
0.92x
Debt/Assets
75.1%
Interest Coverage
3.07x
Long-term Debt
3.8B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-29T14:09:59.228471 |
Data as of: 2026-03-31 |
Powered by Claude AI